The US pharmaceutical company Eli Lilly on Wednesday announced it experienced utilized for an emergency use authorization (EUA) for a lab-produced antibody remedy from COVID-19, after early demo success showed it decreased viral load, indicators and hospitalization prices. “Our groups have worked tirelessly the past seven months to uncover […]